Evidence map›Paper›PMID 34449896›Full record

SynthesisJournal of medical virology2022

Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis.

Sawai Singh Rathore, Nabeel Hussain, Ade Harrison Manju, Qingqing Wen, Sohaib Tousif, Camilo Andrés Avendaño-Capriles, Maria Jose Hernandez-Woodbine, Gianpier Alonzo Rojas, Priyanka Vatsavayi, Chenna Reddy Tera and 4 more

Open access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Pleural macrophages translocate to the lung during infection to promote improved influenza outcomes.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Chest CT as a Prognostic Tool in COVID-19.Archivos de bronconeumologia · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 9 countries.

Sawai Singh RathoreDr. Sampurnanand Medical College, Jodhpur, Rajasthan, India.ORCID 0000-0003-1954-094X
Nabeel HussainSaba University School of Medicine, The Bottom, The Netherlands.
Ade Harrison ManjuClinical Pathology, Faculty of Biochemical Science, University of Yaounde I, Yaounde, Cameroon.
Qingqing WenUniversity of California Los Angeles, Fielding School of Public Health, Los Angeles, California, USA.
Sohaib TousifZiauddin Medical university, Karachi, Pakistan.
Camilo Andrés Avendaño-CaprilesUniversidad del Norte, Barranquilla, Colombia.ORCID 0000-0001-9258-9710
Maria Jose Hernandez-WoodbineUniversidad del Norte, Barranquilla, Colombia.ORCID 0000-0002-1481-617X
Gianpier Alonzo RojasSchool of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0002-4937-0227
Priyanka VatsavayiKamineni Institute of Medical Sciences, Nalgonda, Telangana, India.
Chenna Reddy TeraKamineni Institute of Medical Sciences, Nalgonda, Telangana, India.
Muhammad Adnan AliJinnah Sindh Medical University, Karachi, Pakistan.
Romil SinghDepartment of Critical Care, Mayo Clinic, Rochester, Minnesota, USA.
Shayan SaleemiDepartment of Pulmonology, Aga Khan University Hospital, Karachi, Pakistan.
Deep Manojkumar PatelOur Lady of Fatima University College of Medicine, Valenzuela City, Philippines.
Institute of Medical Sciences · INUniversidad del Norte · COAga Khan University Hospital · PKJinnah Sindh Medical University · PKMayo Clinic · USNetherlands School of Public Administration · NLOur Lady of Fatima University · PHUniversidad Peruana Cayetano Heredia · PEUniversité de Yaoundé I · CMUniversity of California, Los Angeles · USZiauddin University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Observational studies indicate that pleural effusion has an association with risk and the clinical prognosis of COVID-19 disease; however, the available literature on this area is inconsistent. The objective of this systematic review and meta-analysis is to evaluate the correlation between COVID-19 disease and pleural effusion. A rigorous literature search was conducted using multiple databases. All eligible observational studies were included from around the globe. The pooled prevalence and associated 95% confidence interval (CI) were calculated using the random effect model. Mantel-Haenszel odds ratios were produced to report overall effect size using random effect models for severity and mortality outcomes. Funnel plots, Egger regression tests, and Begg-Mazumdar's rank correlation test were used to appraise publication bias. Data from 23 studies including 6234 COVID-19 patients was obtained. The overall prevalence of pleural effusion in COVID-19 patients was 9.55% (95% CI, I

Indexed as

COVID-19FemaleHumansMalePleural EffusionPrevalencePrognosisSeverity of Illness IndexCOVID-19pleural diseasepleural effusionSARS-CoV-2viralX-ray computed tomography

Identifiers

PMID34449896
PMCPMC8662249
OpenAlexW3194002723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.